Treatment of acute bronchiolitis in a resource-limited setting in Port Sudan City: a simple effective regimen by Hassan, Suhair Abdelrahim Osman
Sudan Journal of Medical Sciences
Volume 15, Issue no. 4, DOI 10.18502/sjms.v15i4.8171
Production and Hosting by Knowledge E
Research Article
Treatment of Acute Bronchiolitis in a
Resource-limited Setting in Port Sudan City:
A simple Effective Regimen
Suhair Abdelrahim Osman Hassan
Associate Professor, Consultant Paediatrician and Neonatologist, Port Sudan Paediatric Teaching
Hospital, Red Sea University, Sudan
Abstract
Background: Bronchiolitis is an acute lower respiratory viral infection, caused by the
Respiratory Syncytial Virus (RSV) in 60–85% of cases and other respiratory viruses
in remaining ones. It is the leading cause of hospitalization for infants and toddlers
during the winter and early spring months. At the moment, there is no consensus on
its treatment worldwide. The prevalence is increasing in port Sudan eastern Sudan,
while we have no admission policy or a unified management protocol. Therefore, the
aim of this study is: (1) to formulate an admission policy and a new simple management
protocol; (2) to determine the factor(s) that increased the prevalence in port Sudan as
a secondary objective; and (3) to compare the outcome in the study (119 infants) and
historical (135 infants) groups concerning the hospitalization length and death rate as
a primary objectives.
Method: This is a hospital-based, controlled clinical trial (CCT) study, demographic
data were collected by a questionnaire, and data were analyzed manually. Severity
criteria for acute bronchiolitis are defined. A management guideline was defined and
applied to bronchiolitis cases (119 case) with intention to treat, from October to April
each year (2013–2015). All infants aged between 1 and 23 months with only acute
bronchiolitis were included, while cases with bronchiolitis and associated dysmorphic
features, heart disease, tracheo-oesophageal fistula, other respiratory diseases, other
morbidities, infants below one month or above two years were excluded from this
study. The outcome was compared to a group of matched infants with bronchiolitis
(135 cases) who received antibiotics, B2 agonist, and steroids, between October and
April of years 2011–2012.
Results: While several new lifestyle factors increased the prevalence, the new
guidelines decreased the admission rate (9.6 vs 5.7 mo), is simple and effective, less
expensive, and the duration of hospitalization also reduced (p = 0.04).
Keywords: acute bronchiolitis, resource-limited settings, advanced respiratory
intervention, simple effective intervention,S-7Pro3NO regimen
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1. Introduction
Bronchiolitis is the leading cause of hospital visits and admission among infants and
toddlers during the winter and early spring months [1], causing small airways obstruction
and air trapping [2–4], especially among urban population living in flats or apartments,
due to limited space, closer contact, and decreased house ventilation rather than those
living in large houses with compounds or villas. Some cultural factors also play a role in
the prevalence and severity of the disease, such as avoiding bathing infants in winter
months in order to prevent them from cold or the lack of knowledge on the importance
of hand washing. Many viruses like Metapneumovirus, Adenovirus, Influenza and Para
influenza, Rhinovirus and human bocavirus are accused, but the most common one is
the Respiratory Syncytial Virus (RSV) [1, 2]. Although the peak age for bronchiolitis is
three–six months, it mostly occurs in infants less than four months old, who may need
advanced respiratory support with CPAP and mechanical ventilation [2–6], which is not
always attainable in developing countries and form an obstacle to manage such cases.
Severity is variable – from a mild disease that needs simple intervention and follow-up
(happy wheezers) to a severe one that necessitates intensive care. Fortunately, in Sudan,
severe cases are less common andmost cases are mild to moderate. This is attributed to
the wide, well-ventilated houses, and the abundant sun. There is no specific treatment.
Antibiotics, bronchodilators, and corticosteroids are controversial [2, 4]. Though there is
no consensus between different institutes and even between consultants in the same
hospital, concentrated saline (≥3%) nebulization gained the consensus [5–12]. Most
units use O2, short β2- agonists (salbutamol), antibiotics, and hydrocortisone, resulting
in prolonged hospitalization, morbidity, staff work burden, and parents’ dissatisfaction.
Moreover, in a resource-constrained settings where intensive care facilities are lim-
ited, ways to save lives of infants with severe bronchiolitis should be obtained and
implemented. So, the aim of this study is to (1) formulate an admission policy depending
on the disease severity; (2) create a simple management protocol as there is no
known management protocol for bronchiolitis in Sudan; (3) determine the factor(s) that
increased the prevalence in port Sudan as a secondary objective; and (4) compare
the outcome in the study (119 infants) and historical (135 infants) groups concerning the
hospitalization length and death rate as a primary objectives.
2. Methods
This is an observational, longitudinal study comparing the outcome in the cases of
moderate and severe bronchiolitis, in patients aged 1–23 months, admitted to the Sea
Ports Corporation Hospital (SPCH) in Port Sudan, Sudan, during the winter months
(October–April) of the years 2013–2015 (a total of 119 infant – 9 severe and 110 moderate
cases). Hospital records of all admitted bronchiolitis cases in the years 2011–2012 were
revised, 137 cases were found, 2 were excluded due to associated bacterial pneumonia
in one and dysmorphic features in the other. The remaining 135 infants (7 severe,
128 moderate) in the same age range were compared to the study group. Data were
collected and spread on an Excel sheet and analyzed manually.
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To unify the severity and admission criteria and classification of cases, the following
definitions are made (see Table 1):
1. Severe case is defined by the author as an infant who is sick with spasmodic
cough, tachypnoea (RR 60 bpm or more), severe retractions of the sub-costal area
and tracheal tug, nasal flaring, lethargic or irritable, unable to feed and has type-
two respiratory failure on blood gases or clinical cyanosis while breathing room
air or hypoxic (SPO2 ≤ 90 in room air), with inspiratory and expiratory rhonchi on
lung auscultation.
2. Moderate case is defined by the author as an infant who is unwell, has a spasmodic
cough, tachypnoea (RR 50 –< 60 bpm), with retractions, decreased feeding and
type-1 respiratory failure on blood gases or hypoxia (SPO2 90–94%while breathing
room air), with inspiratory and expiratory rhonchi on lung auscultation.
3. Mild case is defined by the author as an infant who is well with spasmodic cough
but no tachypnoea ( RR ≤ 50 bpm), has mild or no retractions, pink (SPO2 ≥ 96
%) while breathing room air and feeding well with rhonchi on lung auscultation.
TABLE 1: Definition of the severity phenotype.
Criterion Severe Moderate Mild
General condition Lethargic/irritable Unwell Well
RR (bpm) ≥60 50 –< 60 < 50
Retractions Severe Present Mild/no
SPO2% in room air ≤90 90–94 ≥ 96
Cyanosis ++ +/– –
Blood gases Type 11 RF Type 1 RF Normal
Ability to feed Unable Decreased Normal
A new simple, supportive regimen is defined and implemented by the author, and
applied to all admitted cases (total = 119 case) with intension to treat.
Reg-1 (for severe cases) composed of:
1. Provide vital signs assessment every 2 hr or as needed;
2. Provide nebulized 3% saline or N/S through a high flow O2 ≥ 8 L/min, continuously
or every 1 hr till stabilization;
3. Provide L-epinephrine nebulizer 2.5 ml diluted in 5 ml N/S, every 2–4 hr;
4. Provide Oxygen as needed to maintain SPO2 ≥ 96%;
5. Provide I.V. fluids, 2/3rd of the maintenance, and keep NPO;
6. Provide NGT mucolytic syrup 1.5–2.5 ml every 8 hr, depending on age;
7. Provide nasal care (congestion/obstruction relievers like Sea water nasal spray ±
nasal drops containing ephedrine, plus nasal suctioning when needed);
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8. No antibiotics;
9. No steroids; and
10. No β2 agonist.
Reg-2 (for moderate cases) composed of:
1. Provide vital signs assessment every 2 hr;
2. Provide 10 ml nebulized 3% saline or N/S through a nebulizer, every 2–4 hr;
3. Provide L-epinephrine nebulizer 2.5 ml diluted in 5 ml N/S, every 4–6 hr if needed;
4. Provide Oxygen as needed to maintain SPO2 ≥ 96%;
5. Provide NGT feeds or I.V. fluids if needed or allow direct sucking if possible;
6. Provide oral mucolytic syrup 1.5–2.5 ml every 8 hr, depending on age;
7. Provide nasal care (congestion/obstruction relievers [sea water sprays] ± nasal
drops containing ephedrine, plus nasal suctioning when needed);
8. No antibiotics;
9. No Steroids; and
10. No β2 agonist.
Control group received salbutamol nebulizer, O2, antibiotics, steroids, and fluids or
NGT feeds plus saline nasal drops. The first group (study group) received Reg-1 regimen
(for severe cases), and Reg-2 regimen (for moderate cases).
2.1. Study group
All patients (1–23 months old) to were admitted to the pediatric wards of the Sea
Ports Corporation Hospital (SPCH) in Port Sudan, Sudan with bronchiolitis in the winter
months (October–April) of the years 2013–2015 and received the new regimen without
antibiotics, steroids, or salbutamol nebulizer. The exclusion criteria of the study were
any congenital abnormalities including heart, syndromic infants, and other associated
medical problems or evidence of respiratory bacterial infection. Mild bronchiolitis cases
were followed at the outpatient clinic.
Severe cases were admitted directly to ICU and received continuous, either 3% saline
or N/S (if 3% is not available) nebulization, that is, we put 20 cc NS or 3% saline in the
nebulizer cub and attach it to a humidifier (bubbler) that attached to an oxygen cylinder,
set at 8L O2 or more/min, and the amount of saline was replaced immediately whenever
finished. Adrenaline (L-epinephrine) 2.5 cc (two and half ampoules of 1 mg/1 ml ) diluted
in 5 ml N/S was given as nebulizer every 2 hr, through a face mask, with continuous
monitoring of vital signs. All infants were kept nothing per mouth (NPO), given two-thirds
of their maintenance fluid, plus nasal care with sea water spray (hypertonic saline) as
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needed, ephedrine containing nasal drops for children every 8 hr, plus nasal suctioning
as needed (Reg-1. Infants from this group who improved to moderate state were shifted
to the pediatric ward to continue their treatment of Reg-2).
Moderate cases were admitted to the pediatric ward and received intermittent N/S or
3% saline (every 1–2 hr) nebulization, plus diluted adrenaline nebulization same dose
as above but at a 3–4 hr interval, plus I.V. fluid or NGT feeds, plus same nasal care and
monitoring. Those who improved and reclassified as mild were discharged home with
follow-up.
2.2. Historical control group
This group comprised of 135 patients (7 severe, 128moderate cases), all of them received
the same treatment regimen of: antibiotic ceftriaxone plus β2 agonist nebulization every
4–6 hr plus injectable steroid (hydrocortisone) and other supportive care (I.V. fluids or
NGT feeds, O2/nasal cannula, and NS nasal drops ± nasal suctioning).
3. Results
With the application of the new Regimen, the admission rate decreased significantly
(39.7/season vs 67.5/season, P < 0.5).
In the study group of 119 infants with bronchiolitis, 9 cases (7.6%) were severe, 110
(92.4%) were moderate and no deaths were encountered (Table 2) .
TABLE 2: Severity phenotype and outcome in the study group.
Type Discharged Died Total
Severe 09 (100%) 0 9
Moderate 110 (100%) 0 110
Total 119 0 119
TABLE 3: Severity phenotype and outcome in the control group.
Type Discharged (%) Died (%) Total
Severe 03 (42.9) 0 4 (57.1) 7
Moderate 125 (97.7) 01 (0.8) 128
Total 128 (94.8) 05 (3.7) 135
In the historical control group of 135 infants, 7 were severe and 128 moderate. The
death rate was 3.7% (Table 3) with statistically significant difference from the study group
(P < .04)
The mean hospitalization time in the study group was 6.4 days in severe cases and
4.7 days in the moderate group, while it was 11.1 days in severe cases and 8 days in
moderate cases in the control group, which is again, statistically significant (P < 0.5 )
(see Table 4).
Table 5 summarizes the major differences between the two groups.
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TABLE 4: The mean hospital stay.
MHS∗ (days) Study (1𝑠𝑡 ) group Control (2𝑛𝑑 ) group P-value
Severe cases 6.4 11.1 <0.5
Moderate cases 4.7 8 <0.5
*Mean Hospital Stay
TABLE 5: Comparison between the outcomes in the two groups.
Observation Study group Control group
Total no. of cases 119 135
Severe cases 09 (7.6%) 07 (5.2%)
Moderate cases 110 (92.4%) 128 (94.8%)
Discharged (100%) 119 128 (94.8%)
Deaths 0 (0%) 5 (3.7% )
Many factors are found to contribute to the increasing prevalence of bronchiolitis in
Sudan (Table 6 ). Interestingly, 100% of the carers believed that bath in the winter will
subject/increase the flu illness, while more than 98% were not aware of the importance
of hand washing. About 71% of the cases were residing in flats or unventilated houses,
while 90% were unaware of the importance of opening widows to allow sun and air
exchange. In 88% of the cases, the families were large, and 73% of the mothers were
either illiterate or had received low-grade education, while in 53% there was a smoking
person in the house (see Table 6)
TABLE 6: Contributory factors to bronchiolitis
Contributory factor %
Avoiding bathing infants during the winter months 100%
Unawareness of the importance of hand washing 98.55
Contact with a household common cold/flu case 97%
Unaware of the importance of allowing sun rays and air exchange
(opening the widows) in the house
90%
Large families and overcrowding 88%
Illiterate/low-grade educated mothers/parents 73%
Residence in flats/apartment or a small house 71%
A smoking person inside the house 53%
The application of the stated definitions for the disease severity decreased the
admission rate (39.7/season vs 67.5/season, P < 0.5), thereby decreasing the burden
on the staff and doctors.
The protocol was found to be simple, satisfying, easily kept by the resident doctors
as a treatment package for bronchiolitis, and easily carried out by the nursing staff.
The treatment expenses are found to be much less when antibiotics, β2 agonist, and
steroids are omitted.
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4. Discussion
Of note, there is no similar study on contributory factors to acute bronchiolitis, the
prevalence of acute bronchiolitis is increasing in port Sudan city than what we used to
see previously, primarily due to the changing lifestyle and living in flats with decreased
ventilation, and many other contributory factors, the most prominent being the avoid-
ance of bathing infants during the winter months (due to the widely spread believe in the
Arabic world that bathing increases respiratory diseases, in addition to the unawareness
of the mothers and carers of the importance of hand washing). Residing in flats which
lack good ventilation and sun is an important factor that encourages viruses to live
and persist in the place. The previous Sudanese housing models of large houses with
compounds and good ventilation allowed sun exposure and were therefore unsuitable
for viruses to live or persist. This style has now changed to apartments and flats. Other
factors like poor self-hygiene due to illiteracy, the presence of a smoking person in the
household, and over-extending families living in the same place or the crowding of the
Sudanese social activity play major roles in increasing acute bronchiolitis prevalence
in port Sudan city. Though the incidence is large in the underdeveloped countries
despite the incomplete data according to WHO [13], fortunately, the prevalence of
severe cases in Sudan is much less compared to other countries like Egypt and KSA
(unpublished observational study). The new protocol showed simplicity and acceptance
and effectiveness. No encountered complications nor death, and expenses including
length of hospital stay were significantly less, that is because bronchiolitis is a viral
disease and the use of antibiotics and steroids will decrease the immunity (killing the
normal commensals and suppressing the immune system) subjecting the recipient to
more spread of the virus and hence more prolonged and severe disease. The use of β2
agonist is controversial, as there is no element of bronchospasm in the pathogenesis
of bronchiolitis, but it may help thinning the mucus to ease its excretion. Using the
stated clinical classifying criteria allows diagnosis acute bronchiolitis on clinical basis
only, suits poor-resourced places, and is in agreement of discouraging unnecessary
investigation and unneeded treatment [14].
5. Conclusion
Acute bronchiolitis prevalence is increasing in our city, the Reg- 1 and 2 regimens should
be adopted as a hospital policy in treating bronchiolitis as it proved its efficacy, safety,
and cheapness.
Acknowledgements
The author is greatly indebted to all doctors and nursing staff in the pediatric ward of
our hospital who helped with the current study, as well as to all parents and carers who
gave their trust and acknowledged the way of treatment.
DOI 10.18502/sjms.v15i4.8171 Page 453
Sudan Journal of Medical Sciences Suhair Abdelrahim Osman Hassan
Ethical considerations
This study was approved by the SPCH ethical committee on September 8, 2013.
References
[1] Medline Plus. (2020).Medline Plus Medical Encyclopedia: Bronchiolitis. Retrieved from http://www.nlm.
nih.gov/medlineplus/ency/000975.htm
[2] NSW. (2018). Management of Acute Bronchiolitis. Retrieved from http://www.eih.health.nsw.gov.au/
__data/assets/pdf_file/0010/458884/Clinical-practice-guideline-acute-management-of-bronchiolitis.
pdf
[3] Piedra, P. A. and Stark, A. R. (2013). Bronchiolitis (and RSV) in infants and children (Beyond the Basics)
in UpToDate.
[4] The Royal Children’s Hospital Melbourne. Clinical Guidelines: Bronchiolitis. Retrieved from http://www.
rch.org.au?rchcpg/hospital_clinical_guidelines
[5] Fujiogi, M., Goto, T., Yasunaga, H., et al. (2013). Trends in bronchiolitis hospitalizations in the United
States, 2000–2009. Pediatrics, vol. 132, no. 1, pp. 28–36.
[6] Hall, C. B., Weinberg, G. A., Blumkin, A. K., et al. (2013). Respiratory syncytial virus–associated
hospitalizations among children less than 24 months of age. Pediatrics, vol. 132, no. 2, pp. e341–e348.
[7] Basco, W. T., Jr. (August 23, 2013). Infants with bronchiolitis: what treatment is best? Medscape
Pediatrics.
[8] Shay, D. K., Holman, R. C., Newman, R. D., et al. (1999). Bronchiolitis-associated hospitalizations among
US children, 1980–1996. JAMA, vol. 282, pp. 1440–1446.
[9] Nagakumar, P. and Doull, I. (2012). Current therapy for bronchiolitis. Archives of Disease in Childhood,
vol. 97, no. 9, pp. 827–830.
[10] Midulla, F. (2010). Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants.
Archives of Disease in Childhood, vol. 95, pp. 35–41.
[11] Brandenburg, A. H. (1997). Local variability in respiratory syncytial virus disease severity. Archives of
Disease in Childhood, vol. 77, no. 5, pp. 410–414.
[12] Kneyber, M. C., Brandenburg, A. H., Rothbarth, P. H., et al. (1996). Relationship between clinical severity
of respiratory syncytial virus infection and subtype. Archives of Disease in Childhood, vol. 75, no. 2,
pp. 137–140.
[13] Rudan, I., Tomaskovic, L., Boschi-Pinto, C., et al. (2004). Global estimate of the incidence of clinical
pneumonia among children under five years of age. Bulletin of the World Health Organization, vol. 82,
no. 12, pp. 895–903.
[14] Schroeder, A. R. and Mansbach, J. M. (2014). Recent evidence of management of bronchiolitis. Current
Opinion in Pediatrics, vol. 26, no. 3, pp. 328–333.
DOI 10.18502/sjms.v15i4.8171 Page 454
